TAIO PHAR Japan Exchange

Equities

4581

JP3442850008

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-08 am EDT			5-day change	1st Jan Change
8,580 ^JPY	-0.12%		0.00%	-0.75%

Moodify Ltd announced that it has received $8 million in funding from The Procter & Gamble Company, Toyota Ventures, OurCrowd Ltd., Next Gear Ventures, Taisho Pharmaceutical Holdings Co., Ltd.

October 03, 2021

Moodify Ltd announced that it has received $8 million in an equity round of funding led by The Procter & Gamble Company on October 4, 2021. The transaction included participation from OurCrowd Ltd., Taisho Pharmaceutical Holdings Co., Ltd. returning investors, Toyota Ventures and Next Gear Ventures.

Latest news about TAIO PHAR

Chart TAIO PHAR

Duration

Period

More charts

Company Profile

Taisho Pharmaceutical Holdings Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products, and ethical drugs. The Company operates in two business segments. The Self-Medication segment is engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of ethical drugs. The other business is engaged in the leasing and management of real estate, as well as hotel management business.

Sector

Calendar

2024-05-12 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar